Skip to main content

Myocardial Receptors and Their Interaction with Cardiovascular Drugs

  • Chapter
PET for Drug Development and Evaluation

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 26))

  • 109 Accesses

Abstract

Receptor abnormalities have been documented in myocardial samples obtained by endomyocardial biopsy or during surgery or autopsy. Positron Emission Tomography now allows to obtain noninvasively quantitative determination of regional receptor density and affinity in humans as well as innervation integrity and function. These measurements are based upon the synthesis of a radioligand, usually either a selective receptor antagonist or a false neurotransmitter labeled with a positron-emitting radioisotope. Mathematical compartmental models are fitted to activity vs.time curves obtained during saturation or displacement experiments in order to calculate the rate constants and the receptor density in meaningful regions-of-interest selected in the myocardium. Several receptor classes, adrenergic, muscarinic-cholinergic, peripheral-type benzodiazepine, have thus been characterized in humans. PET can help understand changes in cardiac innervation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allman, K., Wieland, D., Muzik, O., et al.: Carbon-11 Hydroxyephedrine with Positron Emission Tomography for Serial Assessment of Cardiac Adrenergic Neuronal Function after Acute Myocardial Infarction in Human. J. Am. Coll. Cardiol. 22:368–75, 1993.

    Article  PubMed  CAS  Google Scholar 

  • Beau, S.L., and Saffitz, J.E.: Transmural heterogeneity of norepinephrine in failing human hearts. J. Am. Coll. Cardiol. 23:579–595, 1994.

    Article  PubMed  CAS  Google Scholar 

  • Beau, S.L., Tolley, T.K. and Saffitz, J.E.: Heterogeneous transmural distribution of beta-adrenergic receptor subtypes in failing human hearts. Circulation 88:2501–2509, 1993.

    Article  PubMed  CAS  Google Scholar 

  • Berger, G., Mazière, M., Prenant, C, Sastre, J., Syrota, A., and Comar, D.: Synthesis of C-11-propranolol. J.Radioanal. Chem. 74:301–306, 1982.

    Article  CAS  Google Scholar 

  • Berger, G., Prenant, C, Sastre, J., Syrota, A., and Comar, D.: Synthesis of a beta-blocker for heart visualization: [11C]practolol. Int. J. Appl. Radiat. Isot. 34:1556–1557, 1983.

    Article  PubMed  CAS  Google Scholar 

  • Berridge, M., Comar, D., Crouzel, C, and Baron, J.C.: C-11-labelled ketanserin, a selective serotonin S2 antagonist. J. Label. Compds. Radiopharm. 20:73–78, 1983.

    Article  CAS  Google Scholar 

  • Böhm, M., La Rosée, K., Schwinger, R.H. and Erdmann, E.: Evidence for reduction of norepinephrine uptake sites in the failing human heart. J. Am. Coll. Cardiol. 25:146–153, 1995.

    Article  PubMed  Google Scholar 

  • Boullais, C, Crouzel, C, and Syrota, A.: Synthesis of 4-(3-t-Butylamino-2-hydroxypropoxy)-benzimidazol-2(11C)-one (CGP 12177). J.Label. Compds. Radiopharm. 23:565–567, 1986.

    Article  CAS  Google Scholar 

  • Bristow, M.R., Ginsburg, R., Minobe, W., et al.: Decreased catecholamine sentivity and beta-adrenergic receptor density in failing human heart. N. Engl. J. Med. 307:205-211, 1982.

    Article  PubMed  CAS  Google Scholar 

  • Bristow, M.R., Kantrowitz, N.E.,Ginsburg, R., Fowler, M.R.: ß-Adrenergic function in heart muscle disease and in heart failure. J. Mol. Cell. Cardiol. 17:41-52, 1985.

    Article  PubMed  CAS  Google Scholar 

  • Bristow, M.R., Ginsburg, R., Umans, V., et al.: Beta-1 and beta-2 adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta-1 receptor down-regulation in heart failure. Circ. Res. 59:297–309, 1986.

    Article  PubMed  CAS  Google Scholar 

  • Bristow, M.R., Hershberger, R.E., Port, J.D., and Rasmussen, R.: β1 and β2 adrenergic receptor mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol. Pharmacol. 35:295–303, 1989a.

    PubMed  CAS  Google Scholar 

  • Bristow, M.R., Port, J.D., and Gilbert, E.M.: The role of adrenergic receptor regulation in the treatment of heart failure. Cardiovasc. Drug. Ther. 3:971–978, 1989b.

    Google Scholar 

  • Bristow, M.R., Anderson, A.L., Port, JD., et al.: Differences in beta-adrenergic receptor neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 84:1024–1039, 1991.

    Article  PubMed  CAS  Google Scholar 

  • Bristow, M.R., Minobe, W., Rasmussen, R., et al.: ß-Adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J. Clin. Invest. 89:803–815, 1992

    Article  PubMed  CAS  Google Scholar 

  • Bristow, M.R., Minobe, W.A., Raynolds, M.V., et al.: Reduced beta-1 receptor mRNA abundance in the failing human heart. J. Clin. Invest. 92:2737–2745, 1993.

    Article  PubMed  CAS  Google Scholar 

  • Brodde, O.E., Schuler, S., Kretsch, R., et al.: Regional distribution of β-adrenoceptors in the human heart: coexistence of functional β1 and β2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy. J. Cardiovasc. Pharmacol. 8:1235–1242, 1986.

    Article  PubMed  CAS  Google Scholar 

  • Brodde, O.E., Broede, A., Daul, A., Kunde, K. and Michel, M.C. Receptor Systems in the Non-Failing Human Heart. Basic Res. Cardiol. 87:1–14, 1992.

    Article  PubMed  CAS  Google Scholar 

  • Brown, J.H., and Goldstein, D.: Analysis of cardiac muscarinic receptors recognized selectively by nonquatemary but not by quaternary ligands. J. Pharmaco. Exp. Ther. 238: 580–586, 1986.

    CAS  Google Scholar 

  • Brush, J.E., Eisenhofer, G., Garty, M., et al.: Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation 79: 836–844, 1989.

    Article  PubMed  Google Scholar 

  • Calkins, H., Lehmann, M., Allman, K., Wieland, D. and Schwaiger, M. Scintigraphic Pattern on Regional Cardiac Sympathetic Innervation in Patients with Familial long QT Syndrome using Positron Emission tomography. Circulation 87:1616–1621, 1993.

    Article  PubMed  CAS  Google Scholar 

  • Camsonne, R., Crouzel, C, Comar, D., et al.: Synthesis of N-(11C)Methyl, N-(Methyl-1 Propyl), (Chloro-2 Phenyl)-1 Isoquinoleine carboxamide receptors. J. Label. Compds. Radiopharm. 21:985–991, 1984.

    Article  CAS  Google Scholar 

  • Chang, P.C., Szemeredi, K., Grossman, E., Kopin, I.J., and Goldstein, D.S.: Fate of tritiated 6-fluorodo-pamine in rats: a false neurotransmitter for positron emission tomographic imaging ol sympathetic innervation and function. J. Pharmacol. Exp. Ther. 255:809–17, 1990.

    PubMed  CAS  Google Scholar 

  • Changeux, J.P.: The acetylcholine receptor: an “allosteric” membrane protein. Harvey Lect. 75:85–254, 1981.

    CAS  Google Scholar 

  • Charbonneau, P., Syrota, A., Boullais, C, and Crouzel, C: Serotonin receptors and lung phagocyte recruitment induced by cigarette smoking detected in vivo by positron emission tomography. J. Nucl. Med. 27:950, 1986.

    Google Scholar 

  • Charbonneau, P., Syrota, A., Crouzel, C, Valois, J.M., Prenant, C, and Crouzel, M.: Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography. Circulation 73:476–483, 1986.

    Article  PubMed  CAS  Google Scholar 

  • Chidsey, C.A., Braunwald, E., and Morrow, A.G.: Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Am. J. Med. 39:442–451, 1965.

    Article  PubMed  CAS  Google Scholar 

  • Clerc, J., Mardon, K., Galu, J.M.,et al.: MBBG versus MIBG for imaging and targeting of the xenografted PC12-pheochromocytoma cell line with SIMS microscopy assessment of their intratumor biodistribution and uptake. J. Nucl. Med. 1995 (in press)

    Google Scholar 

  • Cohn, J.N., Levine, B.T., Olivari, M.T., et al.: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311:819–823, 1984.

    Article  PubMed  CAS  Google Scholar 

  • Colucci, W.S., Denniss, A.R., Leatherman, G.F., et al. .: Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. J. Clin. Invest. 81:1103–1110, 1988.

    Article  PubMed  CAS  Google Scholar 

  • Crouzel, C, Venet, M., Irié, T., Sanz, G., and Boullais, C: Labeling of a serotoninergic ligand with 18F: [18F]setoperone. J. Label. Compds. Radiopharm. 25:403–414, 1988a.

    Article  CAS  Google Scholar 

  • Crouzel, C, Venet, M., Sanz, G., and Denis, A.: Labelling of a new serotoninergic ligand: [18F]ritanserine. J. Label. Compds. Radiopharm. 25:827–832, 1988b.

    Article  CAS  Google Scholar 

  • Dasilva, J.N., Kilbourn, M.R. and Mangner, T.J. Synthesis of [C-11]Tetrabenazine, a Vesicular Monoamine Uptake Inhibitor, for PET Imaging Studies. Appl.RadiatIsotopes. 44:673–676, 1993.

    CAS  Google Scholar 

  • De Grado, T.R., Hutchins, G.D., Toorongian, S.A., Wieland, D.M. and Schwaiger M. Myocardial kinetics of Carbon-11-Meta Hydroxyephedrine: retention mechanisms and effects of norepinephrine. J. Nucl. Med. 34:1287–1293, 1993.

    Google Scholar 

  • DeGrado, T.R., Mulholland, G.K., Wieland, D.M. and Schwaiger, M. Evaluation of (-)[f-18]fluoroethoxy benzovesamicol as a New Pet Tracer of Cholinergic Neurons of the Heart. Nucl.Med. Biol. 21:189–195, 1994.

    Article  PubMed  CAS  Google Scholar 

  • Delforge, J., Syrota, A., and Mazoyer, B.: Experimental design optimization: theory and application to estimation of receptor model parameters using dynamic positron emission tomography. Phys. Med. Biol. 34:419–435, 1989.

    Article  PubMed  CAS  Google Scholar 

  • Delforge, J., Syrota, A. and Mazoyer, B.M. Identifiability Analysis and Parameter Identification of an Invivo Ligand-Receptor Model from Pet Data. IEEE Trans.Biomed.Eng. 37:653–661, 1990a.

    Article  PubMed  CAS  Google Scholar 

  • Delforge, J., Janier, M., Syrota, A., et al.: Noninvasive quantification of muscarinic receptors in vivo with positron emission tomography in the dog heart. Circulation 82:1494–1504, 1990b.

    Article  PubMed  CAS  Google Scholar 

  • Delforge, J., Syrota, A., Lancon, J.P., et al.: Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177 and a new graphical method. J. Nucl. Med. 32:739–748, 1991.

    PubMed  CAS  Google Scholar 

  • Delforge, J., Leguludec, D., Syrota, A., et al.: Quantification of Myocardial Muscarinic Receptors with PET in Humans. J.Nucl.Med. 34:981–991, 1993.

    PubMed  CAS  Google Scholar 

  • Ding, Y., Fowler, J., Dewey, S., et al.: Comparaison of High Specific Activity (-) and (+)−6 [18F]Fluoronorepinephrine and 6-[18F]Fluorodopamine in baboons: heart uptake, metabolism and the effect of desipramine. J. Nucl. Med. 34:619–629, 1993.

    PubMed  CAS  Google Scholar 

  • Ehrin, E., Luthra, S.K., Crouzel, C, and Pike, V.W.: Preparation of carbon-11 labelled prazosin, a potent and selective alpha-1 adrenoceptor antagonist. J. Label. Compds. Radiopharm. 25:177–183, 1988.

    Article  CAS  Google Scholar 

  • Farde, L, Haldin, C, Nagren, K. et al.: Positron emission tomography shows high specific uptake of racemic carbon-11 labelled norepinephrine in the primate heart. Eur. J. Nucl. Med. 21:345–347, 1994.

    Article  PubMed  CAS  Google Scholar 

  • Gibson, R.E., Eckelman, W.C., Vieras, F., and Reba, R.C: The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both triated) in rat, guinea pig and rabbit. J. Nucl. Med. 20:865–870, 1979.

    PubMed  CAS  Google Scholar 

  • Gitler, M.S., Delacruz, R., Zeeberg, B.R. and Reba, R.C. [H-3]QNB displays in vivo selectivity for the m2 subtype. Life Sci. 55:1493–1508, 1994.

    Article  PubMed  CAS  Google Scholar 

  • Goldstein, D.S., Chang, P.C., Eisenhofe,r G., et al.: Positron Emission tomographic imaging of cardiac sympathetic innervation and function. Circulation 81:1606–1621, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Golf, S., Lfvstad, R., and Hansson, V.: beta-adrenoceptor density and relative number of beta-adrenoceptor subtypes in biopsies from human right atrial, left ventricular and right ventricular myocard. Cardiovasc. Res. 19:636–641, 1985.

    Article  PubMed  CAS  Google Scholar 

  • Golf, S., Myrhe, E., Abdelnoor, M., Andersen, D and Hansson, V.: Hypertrophic cardiomyopathy characterized by beta-adrenoceptor density, relative amount of beta-adrenoceptor subtypes and adenylate cyclase activity. Cardiovasc. Res. 19:693–699, 1985.

    Article  PubMed  CAS  Google Scholar 

  • Gossuin, A., Maloteaux, J.M., Trouet, and Laduron, P.: Differentiation between ligand trapping into intact cells and binding on muscarinic receptors. Biochim. Biophys. Acta. 804:100–106, 1984.

    Article  PubMed  CAS  Google Scholar 

  • Hammadi, A., and Crouzel, C.: Asymetric synthesis of (2S) and (2R)-4-(butylamino-2-hydroxypropoxy-benzamidazol-2-C-11) one ((S) and (R) (C-11 CGP 12177 from optically active precursors. J. Lab. Compds. Radiopharm. 29: 681–690, 1991.

    Article  CAS  Google Scholar 

  • Hartvig, P., Lindner, K.J., Tedroff, J. and Langstrom, B. Positron emission tomography-illuminating in vivo drug disposition. Eur.J.Pharm.Sci. 2:44–46, 1994.

    Article  CAS  Google Scholar 

  • Heitz, A., Schwartz, J., and Velly, J.: Beta-adrenoceptors of the human myocardium: determination of β1 and β2 subtypes by radioligand binding. Br. J. Pharmacol. 80:711–717, 1983.

    Article  PubMed  CAS  Google Scholar 

  • Hertel, C, Muller, P., Portenier, H., and Staehelin, M.: Determination of the desensitization of beta-adrenergic receptors by [3H]CGP-12 177. Biochem. J. 216:669–674, 1983.

    PubMed  CAS  Google Scholar 

  • Hoover, D.B., Baisden, R.H. and Ximoy, S.X. Localization of muscarinic receptor mRNAs in rat heart and intrinsic cardiac ganglia by in situ hybridization. Circ.Res. 75:813–820, 1994.

    Article  PubMed  CAS  Google Scholar 

  • Hulme, E.C., Birdsall, N.J.M. and Buckley, N.J. Muscarinic receptor subtypes. Annu.Rev.Pharmacol.Toxicol. 30:633–673, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Karliner, J.S., Stevens, M., Grattan, M., Woloszyn, W., Honbo, N., and Hoffman, J.I.E.: Beta-adrenergic receptor properties of canine myocardium: effects of chronic myocardial infarction. J. Am. Coll. Cardiol. 8:349-356, 1986.

    Article  PubMed  CAS  Google Scholar 

  • Kaumann, A.J.: Some aspects of heart beat adrenoreceptor function. Cardiovasc. Drugs Ther. 5:549–560, 1991.

    CAS  Google Scholar 

  • Kelly, R.B. Storage and Release of Neurotransmitters. Neuron 10 suppl:43–53, 1993.

    Article  Google Scholar 

  • Kilboum, M.R., Jung, Y.W., Haka, M.S., Gildersleeve, D.L, Kuhl, D.E., and Wieland, D.M.: Mouse brain distribution of a carbon-11 labeled vesamicol derivative: presynaptic marker of cholinergic neurons. Life. Sci. 47:1955–63, 1990.

    Article  Google Scholar 

  • Kiuchi, K., Sato, N., Shannon, R.P., Vatner, D.E., Morgan, K. and Vatner, S.F. Depressed beta-Adrenergic Receptor-Mediated and Endothelium-Mediated Vasodilation in Conscious Dogs with Heart Failure. Circ.Res. 73:1013–1023, 1993.

    Article  PubMed  CAS  Google Scholar 

  • Lefroy, D.M. de Silva, R., Choudhury, L. et al.: Diffuse reduction in myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. J. Am. Coll. Cardiol. 22: 1653–1660, 1993.

    Article  PubMed  CAS  Google Scholar 

  • Leguludec, D., Delforge, J., Syrota, A., et al.: In vivo quantification of myocardial muscarinic receptors in heart transplant patients. Circulation 90:172–178, 1994.

    Article  CAS  Google Scholar 

  • Loc’H, C., Mardon, K., Valette, H.,et al.: Preparation and pharmacological characterization of 76-meta-bromobenzylguanidine (76-MBBG). Nucl. Med. Biol. 21:49–55, 1994.

    Article  PubMed  Google Scholar 

  • Maisel, A.S., Motulsky, H.J., and Insel, P.A.: Externalisation of beta-adrenergic receptors promoted by myocardial ischemia.Science 230:183–186, 1985.

    Article  PubMed  CAS  Google Scholar 

  • Maron, B.J., Bonow, R.O., Cannon, R.O., Leon, M.B., and Epstein, S.E.: Hypertrophic cardiomyopathy. N. Engl. J. Med. 316 (13):780–789, 1987.

    Article  PubMed  CAS  Google Scholar 

  • Mazière, M., Comar, D., Godot, J.M., Collard, P., Cepeda, P., and Naquet, R.: In vivo characterization of myocardium muscarinic receptors by positron emission tomography. Life Sci. 29:2391–2397, 1981.

    Article  PubMed  Google Scholar 

  • Melon, P.G., Nguyen, N., Degrado, T.R., Mangner, T.J., Wieland, D.M., Schwaiger, M.: Imaging of cardiac neuronal function after cocaine exposure using C-11-hydroxyephedrine and positron emission tomography. J. Am. Coll. Cardiol. 23:1693–1699, 1994.

    Article  PubMed  CAS  Google Scholar 

  • Merlet, P., Dubois Randé, J.L., Adnot, S., et al.: Myocardial beta adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic cardiomyopathy. J. Cardiovasc. Pharmacol. 19:10–16, 1992a.

    Article  PubMed  CAS  Google Scholar 

  • Merlet, P., Valette, H., Dubois Randé, J.L, et al.: Prognostic value of cardiac MIBG imaging in patients with congestive heart failure. J. Nucl. Med. 33:471–477, 1992b.

    PubMed  CAS  Google Scholar 

  • Merlet, P., Delforge, J., Syrota, A., et al.: Positron Emission Tomography with 11C CGP-12177 to assess β-Adrenergic Receptor Concentration In Idiopathic Dilated Cardiomyopathy. Circulation 87:1169–1178, 1993.

    Article  PubMed  CAS  Google Scholar 

  • Minardo, J.D., Tulli, M.M., Mock, B.H., et al.: Scintigraphic and electrophysiologic evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation 78:1008–1019, 1988.

    Article  PubMed  CAS  Google Scholar 

  • Mislankar, S.G., Gildersleeve, D.L, Wieland, D.M., Massin, G.C., Mulholland, G.K., and Toorongian, S.A.: 6-[18F]fluorometaraminol: a radiotracer for in vivo mapping of adrenergic nerves of the heart. J.Med. Chem. 31:362–366, 1988.

    Article  PubMed  CAS  Google Scholar 

  • Moran, A., Velasco, C, Martin, M. and San Roman, L Pharmacological characterization of 5-HT receptors in parasympathetic innervation of rat heart. Eur. J.Pharmacol. 252:161–166, 1994.

    Article  PubMed  CAS  Google Scholar 

  • Motulsky, H.J. Pet Receptors — Counting Receptors Using Positron Emission Tomography. Circulation 82:1536–1538, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Mukherjee, A., Wong, T.M., Buja, L.M., Lefkowitz, R.J., and Willerson, J.T.: Beta adrenergic and muscarinic cholinergic receptors in canine myocardium: Effects of ischemia. J. Clin. Invest. 64: 1423–1428, 1979.

    Article  PubMed  CAS  Google Scholar 

  • Mukherjee, A., Bush, L.R., McCoy, K.E., et al.: Relationship between beta-adrenergic receptor numbers and physiological responses during experimental canine myocardial ischemia. Circ. Res. 50:735–741, 1982.

    Article  PubMed  CAS  Google Scholar 

  • Mukherjee, A., Haghani, Z., Brady, J., et al.: Differences in myocardial alpha- and beta-adrenergic receptor numbers in different species. Am. J. Physiol. (Heart Circ. Physiol. 14) 245:H957–H961, 1983.

    CAS  Google Scholar 

  • Mulholland, G.K., Schwaiger, M., Sherman, P.S., Jewett, D.M., and Otto, C.A.: New positron labeled quatemized muscarinic ligand as potential PET imaging agent. Circulation 78:11–598, 1988.

    Google Scholar 

  • Mulholland, G.K., Jung, Y.W., Wieland, D.M., Kilboum, M.R. and Kuhl, D.E. Synthesis of [F-18]Fluoroethoxy-Benzovesamicol, a Radiotracer for Cholinergic Neurons. J.Label.Compound.Radiopharm. 33:583–591, 1993.

    Article  CAS  Google Scholar 

  • Murphee, S.S.,and Saffitz, J.E.: Distribution of adrenergic receptors in failing human heart: Implications for mechanisms of down regulation. Circulation 79:1214–1225, 1989.

    Article  Google Scholar 

  • Nakajima, K., Bunko, H., Taki, J., Shimizu, M., Muramori, A., and Hisada, K.: Quantitative analysis of 123l-metaiodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy. Am. Heart. J. 119:1329–1337, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Nanoff, C, Freissmuth, M., and Schütz, W.: The role of a low beta-1 adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands. Naunyn-Schmiedeberg’s Arch Pharmacol. 336:519–525, 1987.

    CAS  Google Scholar 

  • Pascal, O., Syrota, A., Berger, G., et al.: Lung uptake of C-11-lmipramine and C-11-Propranolol in patients with sarcoïdosis evaluated by positron emission tomography, in J. Marsac, J. Chretien (eds): Sarcoïdosis and other granulomatous disorders, Pergamon Press, Paris,, 404–408, 1981.

    Google Scholar 

  • Petch, M.C., and Nayler, W.G.: Uptake of catecholamines by human cardiac muscle in vitro. Br. Heart. J. 41:336–339, 1979.

    Article  PubMed  CAS  Google Scholar 

  • Prenant, C, Sastre, J., Crouzel, C, and Syrota, A.: Synthesis of C-11-Pindolol. J. Label. Compds.Radiopharm. 24:227–232, 1987.

    Article  CAS  Google Scholar 

  • Rogers, G.A., Stoneelander, S., Ingvar, M., Eriksson, L, Parsons, S.M. and Widen, L. F-18-Labelled Vesamicol Derivatives - Syntheses and Preliminary in Vivo Small Animal Positron Emission Tomography Evaluation. Nucl.Med. Biol. 21:219–230, 1994.

    Article  PubMed  CAS  Google Scholar 

  • Rose, C, Burgess, J.H., and Cousineau, D.: Tracer norepinephrine kinetics in coronary circulation of patients with heart failure secondary to chronic pressure and volume overload. J. Clin. Invest. 76:740–747, 1985.

    Article  Google Scholar 

  • Rosenspire, K.C., Haka, M.S., Van Dort, M.E., et at.: Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J. Nucl. Med. 31:1328–34, 1990.

    PubMed  CAS  Google Scholar 

  • Sandoval, A.B., Gilbert, E.M., Rose, C.P., and Bristow, M.B.: Cardiac norepinephrine uptake and release is decreased in dilated cardiomyopathy (abstr). Circulation 80 (suppl. II):393, 1989.

    Google Scholar 

  • Schwaiger, M., Guibourg, H., Rosenpire, K., et al.: Effect of Regional Myocardial Ischemia on sympathetic nervous systems as assessed by Fluorine-18-Metaraminol. J. Nucl. Med. 31:1352–1357, 1990a.

    PubMed  CAS  Google Scholar 

  • Schwaiger, M., Kalff, V., Rosenpire, K., et al.: Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 82:457–464, 1990b.

    Article  PubMed  CAS  Google Scholar 

  • Schwaiger, M., Hutchins, G.D., Kalff, V., et al.: Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography. J. Clin. Invest. 87: 1681–90, 1991.

    Article  PubMed  CAS  Google Scholar 

  • Seto, M., Syrota, A., Crouzel, C, et al.: Beta adrenergic receptors in the dog heart characterized by C-11-CGP 12 177 and PET. J. Nucl. Med. 27:949, 1986.

    Google Scholar 

  • Simon, G., Filep, J. and Zelles, T. Alpha-Adrenergic Drugs Inhibit <H-3>-QNB Binding to Muscarinic Receptors of Rat Heart, Brain and Parotid Gland Membranes. Life Sci. 47:2021–2025, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Spann, J.F., Chidsey, C.A., Pool, P.E., and Braunwald, E.: Mechanism of norepinephrine depletion in experimental heart failure produced by aortic constriction in the guinea pig. Circ. Res. 17:312–321, 1965.

    Article  PubMed  CAS  Google Scholar 

  • Staehelin, M., Simons, P., and Jaeggik Wigger, N.: CGP-12 177. A hydrophilic beta-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J. Biol. Chem. 258:3496–3502, 1983.

    PubMed  CAS  Google Scholar 

  • Stiles, G.L., Caron, M.G., and Lefkowitz, R.J.: ß-Adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol. Rev. 64:661–743, 1984.

    PubMed  CAS  Google Scholar 

  • Syrota, A., Paillotin, G., Davy, J.M., and Aumont, M.C.: Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by Positron Emission Tomography. Life Sci. 35:937–945, 1984.

    Article  PubMed  CAS  Google Scholar 

  • Syrota, A., Comar, D., Paillotin, G., et al.: Muscarinic cholinergic receptor in the human heart evidenced under physiological conditions by positron emission tomography. Proc. Natl. Acad. Sci. USA 82:584–588, 1985.

    Article  PubMed  CAS  Google Scholar 

  • Syrota, A.: Positron Emission Tomography: Evaluation of cardiac receptors. In: Marcus ML, Skorton DJ, Schelbert HR, Wolf GL, eds, Braunwald E (consulting ed); Cardiac Imaging — Principles and practice: a companion of Braunwald’s heart disease. Eds, E. Braunwald, consulting ed., W.B. Saunders Comp., pp 1256–1270, 1991.

    Google Scholar 

  • Takahashi, N., Barber, M.J., and Zipes, D.P.: Efferent vagal innervation of canine ventricle. Ann. J. Physiol. (Heart. Circ. Physiol. 17) 248:H89–H97, 1985.

    CAS  Google Scholar 

  • Thomas, J.A., Marks, B.H.. Plasma norepinephrine in congestive heart failure. Am. J. Cardiol. 41:233–243, 1978.

    Article  PubMed  CAS  Google Scholar 

  • Ungerer, M., Bohm, M., Elce, J.S., Erdmann, E., Lohse, M.J.: Altered expression of beta-adrenergic receptor kinase and beta-1 adrenergic receptors in the failing human heart. Circulation 87:454–463, 1993.

    Article  PubMed  CAS  Google Scholar 

  • Valette, H, Loc’h, C, Mardon, K, et al.:. 76Br-Metabromobenzylguanidine: a PET radiotracer for mapping of sympathetic nerves of the heart. J. Nucl. Med. 34, 10: 1739–1744, 1993.

    PubMed  CAS  Google Scholar 

  • Van Dort, M.E., Gildersleeve, D.L, and Wieland, D.M.: Synthesis of 3H-labeled sympathomimetic amines for neuronal mapping. J. Label. Compounds. Radiopharm. 28:832–40, 1990.

    Google Scholar 

  • Van Zuiten, P.A. Adrenergic and muscarinic receptors: classification, pathophysiological relevance and drug target. J.Hypertension 9:S18–S27, 1991.

    Google Scholar 

  • Vatner, D.E., Lavallee, M., Amano, J., Finizola, A., Homcy, C.J., and Vatner, S.F.: Mechanisms of supersensitivity to sympathetic amines in the chronically denervated heart of the conscious dog. Circ. Res. 57:55–64, 1985a.

    Article  PubMed  CAS  Google Scholar 

  • Vatner, D.E, Vatner, S.F., Fujii, A.M., and Homcy, C.J.: Loss of high affinity cardiac beta adrenergic receptors in dogs with heart failure. J. Clin. Invest. 76: 2259–2263, 1985b.

    Article  PubMed  CAS  Google Scholar 

  • Vatner, D.E., Knight, D.R., Shen, Y.T., Thomas, J.X. Jr, Homcy, C.J., and Vatner, S.F.: One hour of myocardial ischemia in conscious dogs increases beta-adrenergic receptors, but decreases adenylate cyclase activity. J. Mol. Cell. Cardiol. 20:75-82, 1988a.

    Article  PubMed  CAS  Google Scholar 

  • Vatner, D.E., Lee, D.L., Schwarz, K.R., et al.: Impaired cardiac muscarinic receptor function in dogs with heart failure. J. Clin. Invest. 81:1836–1842, 1988b.

    Article  PubMed  CAS  Google Scholar 

  • Wieland, D.M., Brown, L.E., Les Roger, W., et al.: Myocardial imaging with a radioiodinated norepinephrine storage analog. J. Nucl. Med. 22:22–31, 1981.

    PubMed  CAS  Google Scholar 

  • Wieland, D.M., Hutchins, G.D., Rosenspire, K.C., et al.: (C11)Hydroxyephedrine: a high specific activity alternative to 6-(F18)fluorometaraminol for heart neuronal imaging. J. Nucl. Med. 30, 5:767, 1989.

    Google Scholar 

  • Wieland, D.M., Rosenpire, K.C., Hutchkins, G.D., et al.: Neuronal mapping of the heart with 6-18F fluorometaraminol. J. Med. Chem. 33:956–964, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Wieland, D.M.: Heart neuronal imaging with C-11- and fluorine-18-labeled tracers. In: «What’s news in cardiac imaging?», E.E. van der Wall, H. Sochor, H. Righetti and M.G. Niemeyereds, Kluwer Academic Publisher, 413–426, 1992.

    Chapter  Google Scholar 

  • Wilkinson, M., Horackova, M. and Giles, A. Reduction of Ventricular M(2) Muscarinic Receptors in Cardiomyopathic Hamster (Chf 147) at the Necrotic Stage of the Myopathy. Pflugers Arch-Eur. J.Physiol. 426:516–523, 1994.

    Article  CAS  Google Scholar 

  • Woods, P.B., Robinson, M.L: An investigation of the comparative liposolubilities of β-adrenoceptor blocking agents. J. Pharm. Pharmacol. 33:172–173, 1981.

    Article  PubMed  CAS  Google Scholar 

  • Yang, CM., Yeh, H.M., Sung, T.C., Chen, F.F. and Wang, Y.Y. Characterization of Muscarinic Receptor Subtypes in Canine Left Ventricular Membranes. J.Recept.Res. 12:427–449, 1992

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Syrota, A., Merlet, P. (1995). Myocardial Receptors and Their Interaction with Cardiovascular Drugs. In: Comar, D. (eds) PET for Drug Development and Evaluation. Developments in Nuclear Medicine, vol 26. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0429-6_21

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-0429-6_21

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4191-1

  • Online ISBN: 978-94-011-0429-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics